Indo Bioactive Labs

Pune, India Founded: 2001 • Age: 25 yrs
CDMO services are provided for heparin and peptide therapeutics development.

About Indo Bioactive Labs

Indo Bioactive Labs is a Healthcare company based in Pune (India) founded in 2001. CDMO services are provided for heparin and peptide therapeutics development. Indo Bioactive Labs has raised $115.1 thousand across 1 funding round from investors including Sunfruits. Indo Bioactive Labs was last valued at $116.5 thousand in March 2007. Its Indian entity Indo-Bio Active Labs Private Limited reported revenue of β‚Ή3.95 Cr. Indo Bioactive Labs offers products and services including Generic Peptide APIs, Other APIs, and Formulations. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.

Company details

Indo Bioactive Labs was established in 2001 and is based in Pune, India. Operations are focused on the biotechnology and pharmaceutical sectors, where contract development and manufacturing organization (CDMO) services are delivered. Specialization occurs in the creation of heparin-based and peptide therapeutics, supporting research and production needs for pharmaceutical clients. The company maintains facilities in India to handle these processes.

  • Headquarters Pune, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website indobio.com
  • Legal Name Indo-Bio Active Labs Private Limited
  • Date of Incorporation 15 Feb, 1999
  • Jurisdiction Pune, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹3.95 Cr

    FY 2025 · -17% YoY

  • Net Loss
    -₹4.2 Lakh

    FY 2025 · -1% margin

  • EBITDA
    ₹12.5 Lakh

    FY 2025 · 3% margin

  • Total Equity Funding
    $115.1K (USD)

    in 1 rounds

  • Latest Funding Round
    $115.1K (USD), Seed

    Mar 2007

Products & Services of Indo Bioactive Labs

Indo Bioactive Labs offers a comprehensive portfolio of products and services, including Generic Peptide APIs, Other APIs, and Formulations.

Generic Peptide APIs
API Manufacturing

Develops generic peptide active ingredients for pharmaceuticals.

Other APIs
API Manufacturing

Manufactures various active pharmaceutical ingredients.

Formulations
Drug Formulations

Produces formulated pharmaceutical products for medical use.

Funding Insights of Indo Bioactive Labs

Indo Bioactive Labs has successfully raised a total of $115.1K through 1 strategic funding round. The most recent funding activity was a Seed round of $115.1 thousand completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $115,097
  • Total Rounds 1
  • Last Round Seed β€” $115,097
  • First Round $115,097

    (Mar 2007)

  • Investors Count 1

All 1 funding rounds of Indo Bioactive Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2007$115,097Seed$116,498Sunfruits
–
Valuation history

Last known valuation $116,498 (Mar 2007). 1 investors in total: 1 institutional.

Investors in Indo Bioactive Labs

Indo Bioactive Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sunfruits.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
sunfruits.tcc.mode
Premium access

Investor details for Indo Bioactive Labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Indo-Bio Active Labs Private Limited (Indo Bioactive Labs)

Indo-Bio Active Labs Private Limited is the primary company behind Indo Bioactive Labs. The board of Indo-Bio Active Labs Private Limited currently have 3 directors; the longest-serving is Dinesh Keshari Chand Bothra, appointed in 1999. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Dinesh Keshari Chand Bothra
DIN 00049883
Director15 Feb 199927 yrs 8 moIndo-Bio Active Labs Private Limited
Pragati Dinesh Bothara
DIN 00201068
Director29 Sep 200026 yrsIndo-Bio Active Labs Private Limited
Utkarsh Dinesh Munot
DIN 00049903
Director31 Dec 20187 yrs 9 moIndo-Bio Active Labs Private Limited

Financials of Indo Bioactive Labs

Figures of Indo-Bio Active Labs Private Limited, the primary company behind Indo Bioactive Labs, for FY 2025. Revenue was ₹3.95 Cr (-17% year on year). Net loss was -₹4.2 Lakh (-1% margin). EBITDA was ₹12.5 Lakh (3% margin). Revenue has grown at a compounded annual rate of -9% over three years and +9% over five years.

  • ₹3.95 CrRevenue · FY 2025 · -17% YoY
  • -₹4.2 LakhNet loss · -1% margin
  • ₹12.5 LakhEBITDA · 3% margin
  • ₹11.5 LakhPaid-up capital
  • -9%Revenue CAGR, 3 years
  • +9%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Indo-Bio Active Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Indo Bioactive Labs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Indo Bioactive Labs

2 dated milestones of Indo Bioactive Labs across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Indo Bioactive Labs is founded.
  2. Funding First funding round of $115K.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Indo Bioactive Labs (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Indo Bioactive Labs

Indo Bioactive Labs was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Indo Bioactive Labs is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Indo Bioactive Labs is a funded company, having raised a total of $115.1K across 1 funding round to date. The company's 1st funding round was a Seed of $115.1K, raised on Mar 2007.

The primary company behind Indo Bioactive Labs, Indo-Bio Active Labs Private Limited, reported revenue of β‚Ή3.95 Cr for FY 2025, down 17% year on year.

Indo Bioactive Labs was established in 2001 and is based in Pune, India. Operations are focused on the biotechnology and pharmaceutical sectors, where contract development and manufacturing organization (CDMO) services are delivered. Specialization occurs in the creation of heparin-based and peptide therapeutics, supporting research and production needs for pharmaceutical clients. The company maintains facilities in India to handle these processes.

Indo Bioactive Labs offers Generic Peptide APIs, Other APIs, and Formulations.

Indo Bioactive Labs has 1 investor. Key investors include Sunfruits.

The valuation of Indo Bioactive Labs is $116.5K as of Mar 2007.

Indo Bioactive Labs operates through Indo-Bio Active Labs Private Limited.

The legal entities of Indo Bioactive Labs currently have 3 directors, including Dinesh Keshari Chand Bothra, Pragati Dinesh Bothara, Utkarsh Dinesh Munot.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available